Emerging precision medicine in multiple myeloma: clinical and preclinical landscape of T cell, natural killer cell, and macrophages engaging multi-specific antibodies

Multiple Myeloma (MM) is the third most common hematological malignancy worldwide. Despite advancements in available therapies, MM remains incurable for most patients, mainly due to the early relapse and eventual resistance to therapy, underlining the need for novel drugs. Among these, multi-specifi...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Sarra Mestiri, Laila Assami, Zeenath Safira K. M. Yoosuf, Queenie Fernandes, Dina Moustafa Abo El-Ella, Hesham Elsabah, Maysaloun Merhi, Karama Makni-Maalej, Honar Cherif, Said Dermime, Shahab Uddin, Fares Al-Ejeh
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2026-07-01
Seria:	Frontiers in Immunology
Hasła przedmiotowe:	multi- specific antibodies multiple myeloma NK cell engager macrophage engager T cell engager resistance
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1822508/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!